Oncology Health-Outcomes Liaison

Purpose: The demand for high quality health economic and outcomes research (HEOR) and real‑world evidence (RWE) to support drug development, health technology assessment/access decisions, product differentiation, and clinical decision making continues to increase. The purpose of the LVA Health Outcomes and Medical Engagement (HOME) team is to accelerate equitable patient access and transform healthcare delivery through the execution and communication of bold, high impact science. Primary Responsibilities: The HOL role is dynamic given the complex and ever‑changing U.S. healthcare system, continuous innovation in the medical and pharmaceutical industry, and advances in health information technology and real‑world data. Primary responsibilities include customer engagement and evidentiary support while also enabling collaborations that improve patient outcomes, accelerate equitable patient access, and transform healthcare delivery. This entails serving as Lilly’s field medical and HEOR point of contact for population‑based decision makers. Customer Engagement Independently cultivate and manage relationships with PBDMs, acting as the primary point of contact and collaborating closely with other field roles to ensure a cohesive and aligned approach to stakeholder engagement. Proactively deliver and leverage scientific and value evidence and education (e.g., trial data, RWE, HEOR including observational research, comparative effectiveness, and pharmacoeconomic data) to build and sustain engaging, long‑term relationships with PBDMs, ensuring their needs are met across the portfolio. Synthesize, communicate, and translate complex information packages and/or data into transparent, relevant, objective, and actionable evidence, fostering trust and long‑term engagement with PBDMs by addressing their strategic needs and supporting informed decision‑making related to formulary access and pathways/guideline decisions across portfolio. Develop and execute medical/scientific and value strategy collaborating with internal and field‑based medical and commercial partners to deliver exceptional customer experiences. Provide deep medical/value expertise tailored to the needs of PBDMs including opportunities for clinical optimization or collaboration on medical topics. Proactively utilize and tailor new relevant content to strategically meet and anticipate PBDMs medical and value needs, demonstrating expert knowledge on the latest trends and population health data to enhance decision‑making and foster continuous collaboration. Evidentiary Support & Innovative Collaborations Develop and maintain deep knowledge of clinical, analytic, environmental, and account‑level considerations to facilitate mutually beneficial research collaborations and value‑based arrangements (VBAs) from a medical lens. Identify opportunities to build partnership to co‑create evidence and drive improved patient outcomes across healthcare systems & payer/PBM network including research collaborations, value‑based arrangements, and real‑world data partnerships. Frequently share customer insights, evidence gaps, environmental trends, and stakeholder evidence needs internally to influence evidence generation, dissemination, and asset strategy. Support in developing account engagement plan, providing appropriate input on scientific and value topics. Build proactive, medical/scientific and value relationships that lead to innovative collaborations. US Healthcare System & Environmental Expertise Maintain deep content knowledge regarding therapeutic drug classes, clinical/disease state information, pharmacoeconomics/health outcomes, formulary management, technology assessment/value frameworks, quality measures, health policy expertise along with the ability to utilize available research, and to synthesize, communicate and translate relevant evidence. Stay abreast of emerging science, environmental trends, healthcare policy, and regulatory actions relevant to U.S. population‑based decision‑makers. Serve as a knowledgeable resource for customers and internal partners on a broad set of medical topics, including relevant disease states and therapeutic landscapes, HEOR and RWE, value‑based care, the payer perspective, and value assessment in the U.S. Minimum Qualification Requirements: Advanced degree (PharmD, MD, PhD, MS, MSN, MPH) in a scientific or health related field with relevant experience in health science or health outcomes or Bachelor’s degree in a scientific or health related field with 5+ years of experience in health science or health outcomes. Qualified applicants must be authorized to work in the United States on a full‑time basis. Lilly will not provide support for or sponsor work authorization or visas for this role, including but not limited to F‑1 CPT, F‑1 OPT, F‑1 STEM OPT, J‑1, H‑1B, TN, O‑1, E‑3, H‑1B1, or L‑1. Additional Skills/Preferences: Relevant experience in data analytics and/or HEOR research/application. Experience and expertise in the treatment or management of relevant therapeutic areas. Demonstrated expertise in HEOR (including observational and pharmacoeconomic research) and value assessment which may include experience using real‑world data, AMCP dossiers, FDAMA 114, and pharmacoeconomic models. Significant experience and success in self‑managing priorities and multi‑tasking projects. Experience in field‑based customer‑facing roles in industry (e.g., medical, clinical development, government affairs, HEOR, managed care, sales). Ability to analyze and effectively communicate study findings on a range of clinical and HEOR topics including real‑world data analysis and interpretation. Strong comprehension and communication skills, both written and verbal, including the ability to translate and present complex scientific information in a clear, concise manner. Experience working with or supporting PBDMs (population‑based decision makers). Additional Information: The position is field‑based in the U.S. with periods of high travel (50%+ required). Ability to use field‑based electronic or other communication tools for all aspects of the job is critical. This role is focused on the oncology portfolio. This role is focused on health systems, organized medical groups, regional payers and regional group purchasing organizations. West Geography: Western U.S. (CA, OR, WA, AZ, UT, CO). Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status. Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $151,500 - $244,200. Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision, and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day‑care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees. #J-18808-Ljbffr Initial Therapeutics, Inc.